Novartis | NVS - EPS Earnings Per Share


Novartis reported $2.02 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Bausch Health Companies USD 1.08 0.08 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Canopy Growth CAD -0.08 0.14 Sep/2025
Corcept Therapeutics USD 0.16 0.13 Sep/2025
Drreddys Laboratories INR 0.16 0.04 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Novartis USD 2.02 0.04 Sep/2025
Pacira USD 0.7 0.04 Sep/2025
Perrigo USD 0.8 0.23 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Phibro Animal Health USD 0.08 0.09 Dec/2024
Prestige Brands USD 1.14 0.07 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Sanofi EUR -0.67 3.62 Dec/2025
Supernus Pharmaceuticals USD -0.8 1.2 Sep/2025
Zoetis USD 1.48 0.22 Dec/2025